Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)

Press/Media

Period2 Jun 2024

Media coverage

1

Media coverage

  • TitleFlamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date2/06/24
    PersonsMarshall Posner